Double-Blind Clinical Trial of Arginine Supplementation in the Treatment of Adult Patients with Sickle Cell Anaemia
Background. Sickle cell anaemia (SCA) is the most prevalent monogenic disease in Brazil. In SCA, haemoglobin S (HbS) is formed, which modifies red blood cell morphology. Intravascular haemolysis occurs, in which free Hb and free radicals degrade nitric oxide (NO) and release arginase, which reduces...
主要な著者: | , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Wiley
2019-01-01
|
シリーズ: | Advances in Hematology |
オンライン・アクセス: | http://dx.doi.org/10.1155/2019/4397150 |